This is the authors' abstract. We don't add key points for this paper.
Antimicrobial therapy quickly eradicates susceptible bacilli, but the fight against drug-resistant disease must be waged entirely by host defenses. Knowledge of the two main types of immune response against tuberculosis and of how to manipulate those mechanisms--leading to precisely designed recombinant BCG vaccines--is essential to mounting an effective attack on the current epidemic.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Arthur M. Dannenberg (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: